|
Overview
| Day 1 |
Day
2 | Day 3 | Download
Brochure
| Recommended Short Courses*
|
(SC7) Commercial Considerations for
Cell-Based Therapies (Click
on the title to view the full
description)
|
|
This course will review key considerations, strategies, and pivotal tactics for companies commercializing cell therapeutics and/or products that will be employed in that market. This course will be primarily designed for corporate executives, entrepreneurs, and investors.
Topics included will be:
- an overview of the (current) cell therapy, regenerative medicine, and cells-as-tools market;
- developing and implementing a clinical development strategy that positions a product for optimal reimbursement at or near the time of product launch;
- a review of key challenges facing the industry and how they will/must be addressed; and
- a perspective on the role of various industry stakeholders including device, platform, reagent, investment, service, insurers, clinicians, and therapeutic companies.
Course Instructors:
Lee Buckler, Bed, LLB, Principal, Cell Therapy Group
Dawn Driscoll, Ph.D, M.B.A., Principal, DCi Biotech |
*Seperate Registration Required |
Pre-Conference Short Course
Tuesday, February 24
Current Commercial Considerations for
Cell-Based Therapies
Lee Buckler, Bed, LLB, Principal, Cell Therapy Group
Dawn Driscoll, Ph.D, M.B.A., Principal, DCi Biotech
PLENARY KEYNOTE SPEAKERS
 David Ewing Duncan,
Chief Correspondent, NPR Talk’s “Biotech Nation” and Best Selling
Author “Masterminds”
 Jay M. Tenenbaum, Ph.D., Chairman and Chief Scientist,
CollabRx, Inc.
 James A. Wells, Ph.D., Chair, Department
of Pharmaceutical Chemistry; Professor of Pharmaceutical Sciences,
Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology;
and Director of the Small Molecule Discovery Center, University of California, San Francisco
 Michael J. Yaszemski, Ph.D., M.D., Brigadier General, United States Air
Force Reserves, Professor, Orthopedic Surgery and Biomedical Engineering, Mayo
Clinic College of Medicine
Session Topics Include
The Stem Cell Niche
Controlling And Understanding Differentiation
Therapeutic Themes: Considerations For Cardiac Regeneration
Harnessing Cells For Regenerative Healing
Therapeutic Themes: iPS Cells and Personalized Medicine
NEW! Venture Capital and Emerging Company Forum
Address the topics central to the theme of regenerative medicine
Network with prominent researchers, clinicians, businessmen,
and regulators at the cutting edge of their respective fields
Develop strategies to enable the rapidly expanding therapeutic
potential of regenerative medicine
Overview
| Day 1 |
Day
2 | Day 3 | Download
Brochure
For more information, please contact Mary Ann Brown at:
Cambridge Healthtech Institute
250 First Avenue, Suite #300
Needham, MA 02494
Email: mabrown@healthtech.com
For sponsorship information, please contact:
Carol Dinerstein
Email: dinerstein@healthtech.com
Tel: 781-972-5471
|
2009 Preliminary
Brochure Download
Additional Media
Sponsors
|
